These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6485916)

  • 1. [Liver function in alcoholic patients treated with cyanamide].
    Borja Villegas J
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(3):223-5. PubMed ID: 6485916
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyanamide-induced liver injury in alcoholics.
    Vázquez JJ; Cervera S
    Lancet; 1980 Feb; 1(8164):361-2. PubMed ID: 6101808
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyanamide hepatotoxicity. Incidence and clinico-pathological features.
    Bruguera M; Parés A; Heredia D; Rodés J
    Liver; 1987 Aug; 7(4):216-22. PubMed ID: 3683093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cyanamide hepatotoxicity: various forms of presentation. Apropos of 2 cases].
    Caballería Rovira E; Aragó López JV; Massó Ubeda RM; Vidal Clemente JL; Sanchís Closa A
    Rev Clin Esp; 1986 Jun; 179(2):79-81. PubMed ID: 2942986
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyanamide-induced liver injury. A predictable lesion.
    Vazquez JJ; Guillen FJ; Zozaya J; Lahoz M
    Liver; 1983 Aug; 3(4):225-30. PubMed ID: 6323909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ground glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan).
    Thomsen P; Reinicke V
    Liver; 1981 Mar; 1(1):67-73. PubMed ID: 6294436
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis induced by drugs used as alcohol aversion therapy.
    Vázquez JJ; Diaz de Otazu R; Guillen FJ; Zozaya J; Pardo FJ
    Diagn Histopathol; 1983; 6(1):29-37. PubMed ID: 6307616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver lesion caused by cyanamide. Study of a case and review of the bibliography].
    Sáenz de Santa María J; Moreno Casado J; Sánchez Satrústegui JF
    Rev Esp Enferm Apar Dig; 1988 Apr; 73(4):417-20. PubMed ID: 3291022
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
    Bruguera M; Lamar C; Bernet M; Rodés J
    Arch Pathol Lab Med; 1986 Oct; 110(10):906-10. PubMed ID: 3021086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyanamide hepatotoxicity: various forms of presentation. Apropos of 2 cases].
    Vázquez JJ
    Rev Clin Esp; 1987 May; 180(8):466-7. PubMed ID: 3616033
    [No Abstract]   [Full Text] [Related]  

  • 11. [A 73-year-old patient with discrete changes in hepatic biochemistry].
    Rev Clin Esp; 1989 Mar; 184(5):252-6. PubMed ID: 2772296
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyanamide, ethanol, and liver cell inclusion bodies.
    Obach VR; Valles PJ; Rives FA
    Lab Invest; 1985 Jul; 53(1):116-7. PubMed ID: 2989615
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyanamide-associated alcoholic liver disease: a sequential histological evaluation.
    Yokoyama A; Sato S; Maruyama K; Nakano M; Takahashi H; Okuyama K; Takagi S; Takagi T; Yokoyama T; Hayashida M
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1307-11. PubMed ID: 8561306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic contact dermatitis to cyanamide.
    Fernandez de Corres L; Lejarazu DM
    Contact Dermatitis; 1982 Sep; 8(5):346. PubMed ID: 7140271
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the physiological anti-alcoholic effects of cyanamide and its clinical application].
    MUKASA H
    Seishin Shinkeigaku Zasshi; 1962 May; 64():469-91. PubMed ID: 14477032
    [No Abstract]   [Full Text] [Related]  

  • 16. [Calcium carbimide together with light wine as the cause of heart infarction].
    Beermann B; Edelstam C
    Lakartidningen; 1986 Apr; 83(16):1480. PubMed ID: 3702556
    [No Abstract]   [Full Text] [Related]  

  • 17. Structural hepatic changes associated with cyanamide treatment: cholangiolar proliferation, fibrosis and cirrhosis.
    Moreno A; Vazquez JJ; Ruizdel Arbol L; Guillen FJ; Colina F
    Liver; 1984 Feb; 4(1):15-21. PubMed ID: 6321877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cholestatic hepatitis caused by cyanamide].
    Caminal Montero L; Contreras Uriel MA; Altadill Arregui A; Díaz López JB
    Rev Clin Esp; 1991 Jul; 189(3):153-4. PubMed ID: 1947395
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatopathy from cyanamide. Presentation of a new case].
    Fernández-Fúnez A; Moreno M; Barba MA; Beato JL; Puras A
    An Med Interna; 1992 Aug; 9(8):411. PubMed ID: 1391567
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cyanamide hepatopathy. Presentation of two new cases].
    Santalla Peciña F; Solís García E; Gómez Huelgas R; Sánchez Robles C; Varela Fernández JA
    Rev Esp Enferm Dig; 1991 Feb; 79(2):164-5. PubMed ID: 2059521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.